Ropivacaine Hydrochloride

• CAT Number: A000684
• CAS Number: 132112-35-7
• Molecular Formula: C17H29ClN2O2
• Molecular Weight: 328.9
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide;hydrate;hydrochloride
• InChI: InChI=1S/C17H26N2O.ClH.H2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H;1H2/t15-;;/m0../s1
• InChIKey: VSHFRHVKMYGBJL-CKUXDGONSA-N
• SMILES: CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.O.Cl

Ropivacaine Hydrochloride (CAS 132112-35-7) is the hydrochloride salt of ropivacaine, a local anesthetic of the amide type with analgesic activity. It causes reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the cell membrane of the nerve fibers.

Reference

1: Wen XJ, Li XH, Li H, Liang H, Yang CX, Wang HB. CaMK II γ down regulation protects dorsal root ganglion neurons from ropivacaine hydrochloride neurotoxicity. Sci Rep. 2017 Jul 12;7(1):5262. doi: 10.1038/s41598-017-05678-2. PubMed PMID: 28701796; PubMed Central PMCID: PMC5507888.
2: Fu X, Zeng H, Guo J, Liu H, Shi Z, Chen H, Li D, Xie X, Kuang C. A PLGA-PEG-PLGA Thermosensitive Gel Enabling Sustained Delivery of Ropivacaine Hydrochloride for Postoperative Pain Relief. Chem Pharm Bull (Tokyo). 2017;65(3):229-235. doi: 10.1248/cpb.c16-00471. PubMed PMID: 28250344.
3: Wen X, Lai X, Li X, Zhang T, Liang H. The effects of ropivacaine hydrochloride on the expression of CaMK II mRNA in the dorsal root ganglion neurons. Biomed Pharmacother. 2016 Dec;84:2014-2019. doi: 10.1016/j.biopha.2016.11.018. Epub 2016 Nov 15. PubMed PMID: 27863837.
4: Khajuria A, Fazili MU, Shah RA, Khan FA, Bhat MH, Yaqoob SH, Naykoo NA, Ganai NA. Comparison of Two Doses of Ropivacaine Hydrochloride for Lumbosacral Epidural Anaesthesia in Goats Undergoing Laparoscopy Assisted Embryo Transfer. Int Sch Res Notices. 2014 Sep 25;2014:937018. doi: 10.1155/2014/937018. eCollection 2014. PubMed PMID: 27382609; PubMed Central PMCID: PMC4897202.
5: Shen Y, Ji Y, Xu S, Chen DQ, Tu J. Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics. Drug Deliv. 2011 Jul;18(5):361-6. doi: 10.3109/10717544.2011.557788. Epub 2011 Mar 23. PubMed PMID: 21428705.
6: Eremenko AA, Ziuliaeva TP, Shandruk ID, Kolpakov PE, Egorov VM, Iavorovskiĭ AG. [Continuous epidural infusion of ropivacaine hydrochloride (naropin) during postoperative analgesia in cardiosurgical patients]. Anesteziol Reanimatol. 2003 Sep-Oct;(5):63-7. Russian. PubMed PMID: 14671915.
7: Skarda RT, Muir WW 3rd. Analgesic, behavioral, and hemodynamic and respiratory effects of midsacral subarachnoidally administered ropivacaine hydrochloride in mares. Vet Anaesth Analg. 2003 Jan;30(1):37-50. PubMed PMID: 14498916.
8: Bátai I, Kerényi M, Falvai J, Szabó G. Bacterial growth in ropivacaine hydrochloride. Anesth Analg. 2002 Mar;94(3):729-31; table of contents. PubMed PMID: 11867406.
9: Robustelli della Cuna FS, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM. Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration. Am J Health Syst Pharm. 2001 Sep 15;58(18):1753-6. PubMed PMID: 11571819.
10: Porter JM, Kelleher N, Flynn R, Shorten GD. Epidural ropivacaine hydrochloride during labour: protein binding, placental transfer and neonatal outcome. Anaesthesia. 2001 May;56(5):418-23. PubMed PMID: 11350325.